Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

Modern cancer care is critically dependent on imaging technologies, which are used to detect early tumors and guide their therapy or surgery.

New Survey by Applied Data Research Analyzes Clinical Impact

Siemens Healthcare highlights innovative solutions in molecular imaging at the 2008 Society of Nuclear Medicine (SNM) Scientific Sessions in New Orleans, June 14-18. The Siemens booth (#731) will feature its newest technology, HD-PET, as well as new features in SPECT imaging and imaging biomarker developments.

Applied Data Research Analyzes Recent Advances and Healthcare Impact

Siemens Medical Solutions has expanded its molecular imaging research collaboration with The University of Texas M. D. Anderson Cancer Center with the establishment of a preclinical research center dedicated to the development of new, targeted biomarkers that may help detect cancers earlier, better visualize cancers at the molecular level, and provide more effective, tailored therapies.